Advertisement

The journal of nutrition, health & aging

, Volume 21, Issue 4, pp 413–420 | Cite as

Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: A pragmatic randomized, partially blinded, controlled trial

  • Ana LaizEmail author
  • J. Malouf
  • A. Marin
  • V. Longobardi
  • J. de Caso
  • J. Farrerons
  • J. Casademont
Article

Abstract

Objective

To determine whether 3-monthly supplementation of an oral vitamin D widely used in Spain (calcifediol) plus daily exercise could influence survival at one and four years after surgery for osteoporotic hip fracture.

Design

A pragmatic, randomized, partially single-blind placebo-controlled study.

Setting

Patients admitted to a tertiary university hospital for acute hip fracture.

Participants

675 healthy adult patients undergoing surgery for osteoporotic hip fracture were recruited from January 2004 to December 2007.

Intervention

Patients were randomized to receive either 3-monthly oral doses of 3 mg calcifediol (Hidroferol Choque®) or placebo in the 12 months postsurgery. Patients who received calcifediol were also given an exercise programme. The placebo group received standard health recommendations only.

Measurements

The primary endpoint was survival at 1 year and at 4 year follow-up. We also recorded new fractures, medical complications and anti-osteoporotic treatment compliance.

Results

We included a total of 88 patients, aged 62 to 99 years. Mean age was 82 years and 88.6% were women. At 12 months, 10 (11.3%) patients had died, 9 of them, from the non-intervention group. At 4 years after surgery, 20 (22.7%) had died, 3 (3.4%) from the intervention group and 17 (19.3%) from the non-intervention group. At this time, survival curve analysis showed 93% survival in the intervention group and 62% in the non-intervention group (p=0.001). At 12-month follow up, there were 18 new fractures, 9 in each group. The non-intervention group had more medical complications, with significant differences at visit 2 (p = 0.04) and 3 (p = 0.02) but not at visit 4 (p = 0.18). No significant differences between groups were found regarding treatment compliance.

Conclusion

3-monthly, oral supplements of 3 mg calcifediol plus daily exercise improved survival at one-year and four-year follow up after surgery for an osteoporotic hip fracture.

Key words

Vitamin D survival osteoporosis hip fracture exercise 

Abbreviations

IG

intervention group

NIG

non-intervention group

SD

standard desviation

PTH

parathormone

AST

aspartate aminotransferase

ALT

alanine aminotransferase

GGT

gammaglutamyltransferase

AP

alkaline phosphatase

References

  1. 1.
    Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, et al. Swedish Hip Fracture Study Group. Survival after hip fracture. Osteoporos Int 2005; 16: 1583–90.PubMedGoogle Scholar
  2. 2.
    Jiang HX, Majumdar SR, Dick DA, Moreau M, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 2005; 20: 494–500.CrossRefPubMedGoogle Scholar
  3. 3.
    Lee AY, Chua BS, Howe TS. One-year outcome of hip fracture patients admitted to a Singapore hospital:quality of life post-treatment. Singapore Med J 2007; 48: 996–9.PubMedGoogle Scholar
  4. 4.
    Peterson MG, Cornell CN, Paget SA, Allegrante JP. Five-year survival in a cohort of hip fracture patients: the predictive role of pre-fracture health status. HSS J 2008; 4: 43–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Paksima N, Koval KJ, Aharanoff G, Walsh M, et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis 2008; 66: 111–7.PubMedGoogle Scholar
  6. 6.
    Maggi S, Siviero P, Wetle T, Besdine RW, et al. A multicenter survey on profile of care for hip fracture: predictors of mortality and disability. Osteoporos Int 2009; 21: 223–31.CrossRefPubMedGoogle Scholar
  7. 7.
    Vaseenon T, Luevitoonvechkij S, Wongtriratanachai P, Rojanasthien S. Long-term mortality after osteoporotic hip fracture in Chiang Mai, Thailand. J Clin Densitom 2010; 13: 63–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010; 39: 203–9.PubMedGoogle Scholar
  9. 9.
    Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010; 152: 380–90.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kreutzfeldt J, Haim M, Bach E. Hip fracture among the elderly in a mixed urban and rural population. Age Ageing 1984; 13: 111–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Richmond J, Aharonoff GB, Zuckerman JD, Koval KJ. Mortality risk after hip fracture. J Orthop Trauma 2003;17 Suppl 8:S2–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Parker MJ, Pryor GA, Myles J. 11-year results in 2,846 patients of the Peterborough Hip Fracture Project: reduced morbidity, mortality and hospital stay. Acta Orthop Scand 2000; 71: 34–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Larrosa M, Gratacos J, Vaqueiro M, Prat M, et al. Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc) 2001; 117: 611–4.CrossRefGoogle Scholar
  15. 15.
    Vaqueiro M, Bare M, Anton E, Andreu E, et al. Hypovitaminosis D associated to low sun exposure in the population over 64 years old. Med Clin (Barc) 2007; 129: 287–91.CrossRefGoogle Scholar
  16. 16.
    Bruyere O, Decock C, Delhez M, Collette J, et al. Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study. Womens Health (Lond Engl) 2009; 5: 49–54.CrossRefGoogle Scholar
  17. 17.
    Kanis JA, Burlet N, Cooper C, Delmas PD, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399–428.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Bunout D, Barrera G, Leiva L, Gattas V, et al. Effects of vitamin D supplementation and exercise training on physical performance in chilean vitamin D deficient elderly subjects. Exp gerontol 2006; 41: 746–52.CrossRefPubMedGoogle Scholar
  20. 20.
    Dhesi JK, Jackson SH, Bearne LM, Moniz C, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004; 33: 589–95.CrossRefPubMedGoogle Scholar
  21. 21.
    Houston DK, Cesari M, Ferrucci L, Cherubini A, et al. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007; 62: 440–6.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Stewart JW, Alekel DL, Ritland LM, Van Loan M, et al. Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009; 16: 1093–101.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; CD007146.Google Scholar
  24. 24.
    Zhu K, Devine A, Dick IM, Wilson SG, et al. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab 2008; 93: 743–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004; 80: 752–8.PubMedGoogle Scholar
  26. 26.
    Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; CD007470.Google Scholar
  27. 27.
    Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J of Clin Nutr 2008;87:1080S–6S.Google Scholar
  28. 28.
    Holick MF, Siris ES, Binkley N, Beard MK, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clinical Densitom 2011; 14: 79–84.CrossRefGoogle Scholar
  31. 31.
    Sanders KM, Stuart AL, Williamson EJ, Simpson JA, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815–22.CrossRefPubMedGoogle Scholar
  32. 32.
    Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Lips P, Binkley N, Pfeifer M, Recker R, et al. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J of Clin Nutr 2010; 91: 985–91.CrossRefGoogle Scholar
  34. 34.
    Avenell A, Grant AM, McGee M, McPherson G, et al. The effects of an open design on trial participant recruitment, compliance and retention—a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin Trials 2004; 1: 490–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Harwood RH, Sahota O, Gaynor K, Masud T, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham neck of femur (NONOF) Study. Age Ageing 2004; 33: 45–51.CrossRefPubMedGoogle Scholar
  36. 36.
    Smith H, Anderson F, Raphael H, Maslin P, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007; 46: 1852–7.CrossRefGoogle Scholar
  37. 37.
    Sato Y, Iwamoto J, Honda Y. An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients. J Stroke Cerebrovasc Dis 2011; 20: 41–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J of Steroid Biochem Mol Biol 2004;89-90:497–501.CrossRefGoogle Scholar
  39. 39.
    Ivorra J, Valls E, Fernández-Llanio Comella N, Chalmeta Verdejo I, et al. Monitorización de los valores séricos de vitamina D en mujeres con osteoporosis posmenopáusica tratadas con dosis habituales de vitamina D. Med Clin (Barc) 2012; 138: 199–201.CrossRefGoogle Scholar
  40. 40.
    Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 1988; 10: 64–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83.CrossRefPubMedGoogle Scholar
  43. 43.
    Bliuc D, Nguyen ND, Milch VE, Nguyen TV, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009; 301: 513–21.CrossRefPubMedGoogle Scholar
  44. 44.
    Morin S, Lix LM, Azimaee M, Metge C, et al. Mortality rates after incident nontraumatic fractures in older men and women. Osteoporos Int 2011; 22: 2439–48.CrossRefPubMedGoogle Scholar
  45. 45.
    Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754–9.PubMedGoogle Scholar
  46. 46.
    Oliai Araghi S, van Dijk SC, Ham AC, Brouwer-Brolsma EM, et al. BMI and Body Fat Mass Is Inversely Associated with Vitamin D Levels in Older Individuals. J Nutr Health Aging 2015; 10: 980–5.CrossRefGoogle Scholar
  47. 47.
    Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–56.PubMedGoogle Scholar
  48. 48.
    Grant AM, Avenell A, Campbell MK, McDonald AM, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or vitamin D, RECORD): a randomised placebocontrolled trial. Lancet 2005; 365: 1621–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, et al. Effect of highdosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010; 170: 813–20.CrossRefPubMedGoogle Scholar
  50. 50.
    Langsetmo L, Barr SI, Berger C, Kreiger N, et al. Associations of Protein Intake and Protein Source with Bone Mineral Density and Fracture Risk: A Population-Based Cohort Study. J Nutr Health Aging. 2015; 19: 861–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France 2017

Authors and Affiliations

  • Ana Laiz
    • 1
    Email author
  • J. Malouf
    • 1
  • A. Marin
    • 1
  • V. Longobardi
    • 1
  • J. de Caso
    • 2
  • J. Farrerons
    • 1
  • J. Casademont
    • 1
  1. 1.Internal Medicine Department, C/Sant Antoni Mª Claret 167Hospital de la Santa Creu I Sant PauBarcelonaSpain
  2. 2.Orthopedic Surgery DepartmentHospital de la Santa Creu I Sant PauBarcelonaSpain

Personalised recommendations